Skip to content
BIO FRONTIER
Home
Artificial intelligence
Biotechnology
Genetics
Medical Technology
ZYME
Home
ZYME
Biotechnology
Petri Dish Reports
Uncategorized
ZYME
Zymeworks FY25 Review: From Milestone Volatility To 2026 Upside
Mar 4, 2026
Biotechnology
Uncategorized
ZYME
Zymeworks reports positive phase 3 Ziihera data; cash runway extended beyond 2028
Jan 12, 2026
Search for: